NASDAQ:PRTO

Proteon Therapeutics Stock Predictions

> Biotechnology

Buy PRTO

*Your capital is at risk

$27.88

-0.0562 (-0.201%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

PRTO Prediction Chart

PRTO Predictions History

Latest community submissions for PRTO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 25, 2021	$18.37 +4.32%	$17.61	X	95.68%	0
Kevin Ripper @KevinRipper.214730	Feb 25, 2021	$19.04 +8.12%	$17.61	X	91.88%	0
JS Pro	Aug 13, 2019	$0.313 +2.42%	$0.310	V	99.03%	1
NameNotImportant Pro	May 6, 2019	$0.473 +11.40%	$0.425	X	88.60%	0
JS Pro	Feb 27, 2017	$1.98 +1.54%	$1.95	X	98.50%	0
PIFF	Feb 27, 2017	$0.536 -72.51%	$1.95	X	27.50%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PRTO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT PROTEON THERAPEUTICS INC.

Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in two Phase III clinical trials in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis; has completed a Phase I/II clinical trials ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by